TY - JOUR
T1 - Visual impairment, uncorrected refractive error, and accelerometer-defined physical activity in the United States
AU - Willis, Jeffrey R.
AU - Jefferys, Joan L.
AU - Vitale, Susan
AU - Ramulu, Pradeep Y.
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/3
Y1 - 2012/3
N2 - Objective: To examine how accelerometer-measured physical activity is affected by visual impairment (VI) and uncorrected refractive error (URE). Design: Cross-sectional study using data from the 2003-2004/2005-2006 National Health and Nutritional Examination Survey. Visual impairment was defined as better-eye postrefraction visual acuity worse than 20/40. Uncorrected refractive error was defined as better-eye presenting visual acuity of 20/50 or worse, improving to 20/40 or better with refraction. Adults older than 20 years with normal sight, URE, and VI were analyzed. The main outcome measures were steps per day and daily minutes of moderate or vigorous physical activity (MVPA). Results: Five thousand seven hundred twenty-two participants (57.1%) had complete visual acuity and accelerometer data. Individuals with normal sight took an average of 9964 steps per day and engaged in an average of 23.5 minutes per day of MVPA, as compared with 9742 steps per day and 23.1 minutes per day of MVPA in individuals with URE (P>.50 for both) and 5992 steps per day and 9.3 minutes/d of MVPA in individuals with VI (P<.01 for both). In multivariable models, individuals with VI took 26% fewer steps per day (P<.01; 95% CI, 18%-34%) and spent 48% less time in MVPA (P<.01; 95% CI, 37%-57%) than individuals with normal sight. The decrement in steps and MVPA associated with VI equaled or exceeded that associated with self-reported chronic obstructive pulmonary disease, diabetes mellitus, arthritis, stroke, or congestive heart failure. Conclusions: Visual impairment, but not URE, impacts physical activity equal to or greater than other serious medical conditions. The substantial decrement in physical activity observed in nonrefractive vision loss highlights a need for better strategies to safely improve mobility and increase physical activity in this group.
AB - Objective: To examine how accelerometer-measured physical activity is affected by visual impairment (VI) and uncorrected refractive error (URE). Design: Cross-sectional study using data from the 2003-2004/2005-2006 National Health and Nutritional Examination Survey. Visual impairment was defined as better-eye postrefraction visual acuity worse than 20/40. Uncorrected refractive error was defined as better-eye presenting visual acuity of 20/50 or worse, improving to 20/40 or better with refraction. Adults older than 20 years with normal sight, URE, and VI were analyzed. The main outcome measures were steps per day and daily minutes of moderate or vigorous physical activity (MVPA). Results: Five thousand seven hundred twenty-two participants (57.1%) had complete visual acuity and accelerometer data. Individuals with normal sight took an average of 9964 steps per day and engaged in an average of 23.5 minutes per day of MVPA, as compared with 9742 steps per day and 23.1 minutes per day of MVPA in individuals with URE (P>.50 for both) and 5992 steps per day and 9.3 minutes/d of MVPA in individuals with VI (P<.01 for both). In multivariable models, individuals with VI took 26% fewer steps per day (P<.01; 95% CI, 18%-34%) and spent 48% less time in MVPA (P<.01; 95% CI, 37%-57%) than individuals with normal sight. The decrement in steps and MVPA associated with VI equaled or exceeded that associated with self-reported chronic obstructive pulmonary disease, diabetes mellitus, arthritis, stroke, or congestive heart failure. Conclusions: Visual impairment, but not URE, impacts physical activity equal to or greater than other serious medical conditions. The substantial decrement in physical activity observed in nonrefractive vision loss highlights a need for better strategies to safely improve mobility and increase physical activity in this group.
UR - http://www.scopus.com/inward/record.url?scp=84858611668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858611668&partnerID=8YFLogxK
U2 - 10.1001/archopthalmol.2011.1773
DO - 10.1001/archopthalmol.2011.1773
M3 - Article
C2 - 22411662
AN - SCOPUS:84858611668
SN - 0003-9950
VL - 130
SP - 329
EP - 335
JO - Archives of ophthalmology
JF - Archives of ophthalmology
IS - 3
ER -